Life Technologies Corporation (NASDAQ: LIFE) today announced plans for
the Applied Biosystems SOLiD™ PI System, a new highly accurate, flexible
and easy-to-use genomic analysis platform that will bring
next-generation sequencing within the grasp of all life science research
laboratories worldwide. Early customer adoption of the SOLiD PI System
is expected to begin in the second half of 2010.
“The SOLiD PI System builds on the superior data
quality and accuracy of our SOLiD system chemistry, but delivers it in a
more affordable format that will bring the power of next-generation
sequencing to every laboratory.”
The SOLiD PI System, designed in partnership with Hitachi
High-Technologies Corporation, will provide individual researchers and
sequencing core laboratories with a cost-effective instrument that will
deliver an accuracy level of 99.99 percent. The system uses the same
highly-accurate ligation-based sequencing technology as the SOLiD
4 System, and coupled with a streamlined workflow, is engineered to
deliver high-quality, sample-to-mapped data in as little as two days.
Designed to generate up to 50 gigabases (Gb) of mappable sequence data
per run, equivalent to up to 8 Gb per day, this powerful, yet intuitive
system will support a breadth of next-generation sequencing applications
that include, SNP calling and detection, targeted resequencing, whole
transcriptome analysis and digital gene expression analysis.
The system also addresses the challenges related to capital and run
costs facing scientists engaged in next-generation sequencing. The SOLiD
PI System is anticipated to deliver a next-generation sequencer at a US
list price of $230,000, with a cost per sample as low as $200.
“As sequencing becomes an ever more important tool for scientists to
unlock the mechanisms of disease, it is critical that we provide a range
of system solutions that meet the unique requirements of individual
researchers,” said Kip Miller, President of the Genetic Systems Division
for Life Technologies. “The SOLiD PI System builds on the superior data
quality and accuracy of our SOLiD system chemistry, but delivers it in a
more affordable format that will bring the power of next-generation
sequencing to every laboratory.”
The SOLiD PI System is the latest addition to Life Technologies’
portfolio of sequencing solutions. The company recently announced the
introduction of the SOLiD 4 System, which delivers unprecedented
accuracy in next-generation sequencing. These offerings, along with the
company’s gold-standard capillary electrophoresis (CE) instrumentation,
demonstrate Life Technologies’ commitment to innovation across the
research continuum, supporting sequencing analysis from discovery
through validation and screening.
For more information on the SOliD PI System please visit www.appliedbiosystems.com/solidpi
Can soda taxes fight obesity? New research adds to the debate